We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.10 | -2.30% | 4.25 | 4.00 | 4.50 | 4.35 | 4.25 | 4.35 | 280,756 | 09:58:33 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 1.83M | -2.24M | -0.0042 | -11.90 | 26.67M |
Date | Subject | Author | Discuss |
---|---|---|---|
10/8/2020 12:47 | They haven't - at least hadn't when I asked about it for Mevalone - been applied for for in the UK. This was all down to the systems of the EU which mean that you have to apply to each independent group of countries within the EU. From memory we are in the Northern Group and not to many grapes are grown there. I assume that there are similarities for other products (so blame the EU Process LOL). | speculator59 | |
09/8/2020 13:39 | Felt kinda compelled to post the Greece Mevalone link as I'm in Athens at the moment, K&NE outlet is based about 10 mins from the airport, I'm half tempted to pop in on the trip back and do some field research...like price ? comparison and how many cases have they ordered and do they expect it to fly of the shelf etc... I've had a couple of Kaiser Pilsners in the sun so apols if it doesn't make any sense to anybody else........ | 33mick | |
09/8/2020 12:47 | Hi Mirandaj - You have worked a miracle - or else Eden are watching this thread and have just removed the glitch!! Knew it was a pdf file (I am using foxit) but did not respond this morning! 7995 above now edited!! AGM Q&A - interesting but well hedged!! | pugugly | |
09/8/2020 11:44 | All the links on that page open perfectly well. It might be your computer PUGUGLY. pdf files | mirandaj | |
09/8/2020 11:22 | Follow up to 7994 * The recent appointee came from Plant Health Care - However is this a plus point when the progess of the PHC share price is factored in? * Just been following up the Eden website and neither 24/06/2020 AGM Questions and Answers nor 29/05/2020 2019 Annual Report will open when using standard click to open - Can anyone advise or is the site bust?? Edited -12:52pm Now working and opening OK Looks as though Mirandaj worked a miracle !!! * Not very encouraging that the combinded holing of the directors is 0.8% and current value of their combined holding is some £200,000 - Possibly less than some of the posters (or ex holders on this board) hold/held. However still looking at as appears to be in a very promising (ESG) sustainable area - OK maybe I should concentrate funds elsewhere as (e&oe) No UK agritech company has ever made real money for investors - either (imo) wrong products - scientific dead-end - not offering sufficient extra revenue to the users - or management lack sales skills or as the Yanks would say "The killer instinct" | pugugly | |
09/8/2020 11:00 | Hi SS - Neither of the 2 above patent links refer to Eden - They appear on the face to have have had funding support from US Gov and to have been granted to University of Mass - What am I missing re Eden? | pugugly | |
08/8/2020 15:30 | At some point you'd like to think sales will gain some traction.... Be nice if it ever gets UK approval...prob sat in some civil servants in tray collecting dust! | 33mick | |
08/8/2020 14:50 | You will not find facts just suppositions | chrischas | |
08/8/2020 13:46 | Good afternoon PaulpaoloI have searched TT' website but found no reference to your post, even after following your link. TT's last updated their website in April of this year.Where can I read more on this story?Stay safe. | northwick | |
07/8/2020 20:14 | Source? What are you referring too? | investingisatrickygame | |
05/8/2020 12:44 | Bottom line is Eden BOD has to get their finger out before it’s too late.Its being seen with Biochem Covid testing : you soon get market share taken when a new invention comes out. | chrischas | |
05/8/2020 12:34 | erinvale5 Aug '20 - 09:47 - 7985 of 7985 0 3 0 Sales are key. Eden seem incapable of achieving real sales - they've had 25 years and are still touting authorisations as progress. The market is not that easily fooled. -------------------- To be fair I don't think there's ANY interest in these currently. Any hot money has far warmer places to be; and nervous investors wouldn't be here. Today's RNS hardly makes the pulse race, but it is a sign of progress, albeit overdue. CED is larger than MEV; and of course we're also waiting upon the US to come through. All delayed due to COVID. Bottom line is, EDEN has more than enough cash for time being. And clock is ticking on seeds + Sustaine. | brucie5 | |
05/8/2020 09:47 | Sales are key. Eden seem incapable of achieving real sales - they've had 25 years and are still touting authorisations as progress. The market is not that easily fooled. | erinvale | |
05/8/2020 08:22 | Unmentionable Sales. | supersonico | |
05/8/2020 08:21 | Wow another approval, if only that is all companies had to do to be successful these days... WHAT ABOUT SALES??? | bjlk | |
05/8/2020 07:14 | New authorisation for Cedroz™ in Greece | supersonico | |
04/8/2020 07:48 | Wow all we need now is some sales. | chrischas | |
03/8/2020 18:47 | Unmentionable US patent. No 1 YEAST CELL WALL PARTICLE ENCAPSULATION OF BIODEGRADABLE PRO-PAYLOADS Unmentionable US patent. No 2 COMPOSITIONS CONTAINING A HOLLOW GLUCAN PARTICLE OR A CELL WALL PARTICLE ENCAPSULATING A TERPENE COMPONENT, METHODS OF MAKING AND USING THEM | supersonico | |
02/8/2020 00:04 | Eden is going to 0p | quazie12 | |
01/8/2020 18:59 | 15p would put Eden on a rough P/E of 1.5 assuming the Corteva deal comes through with potential values suggested. That would be a massive share price under performance and lack of recognition for that contractual arrangement. | investingisatrickygame |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions